Earnings Positive

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge

Breaking news from global financial markets

2 months ago
Read More